Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

36.360
+2.4807.32%
Volume:38.82M
Turnover:1.41B
Market Cap:79.92B
PE:-18.87
High:37.060
Open:34.000
Low:34.000
Close:33.880
52wk High:37.060
52wk Low:10.360
Shares:2.20B
HK Float Shares:2.20B
Volume Ratio:1.10
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.927
ROE:-15.33%
ROA:1.54%
PB:2.62
PE(LYR):-18.87
PS:12.06

Loading ...

Movement Alert|GENSCRIPT BIO Rises 5.07% in Regular Trading, CARVYKTI Q2 Sales Surge Nearly 50% YoY as Interim Results Review Approaches

Market Focus
·
Aug 06

GenScript Partners with Tamarind Bio to Link AI Molecular Design with Wet-Lab Validation

Reuters
·
Aug 06

GenScript Bio Sets 15 Aug 2026 U.S. Board Meeting to Approve 1H26 Interim Results and Dividend Proposal

Bulletin Express
·
Aug 05

GenScript Biotech Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 05

CRO Stocks Surge Pre-Noon with GenScript Biotech and WuXi Apptec Both Jumping Over 11%

Deep News
·
Aug 04

Hong Kong Stocks Midday Review: Hang Seng Index Dips 0.49% as Optical Communication Sector Surges Against the Trend

Stock News
·
Aug 04

CRO Stocks Surge: Multiple Overseas MNCs and CXO Firms Report Strong Interim Results, Raise Full-Year Guidance

Stock News
·
Aug 04

Movement Alert|GENSCRIPT BIO Rises 5.15% in Regular Trading, CARVYKTI Q2 Sales Surge Nearly 50% YoY Combined with Pipeline Progress

Market Focus
·
Aug 04

Movement Alert|GENSCRIPT BIO Rises 6.04% in Regular Trading, CARVYKTI Q2 Sales Surge Nearly 50% YoY Continues to Boost Sentiment

Market Focus
·
Aug 03

Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%

Stock News
·
Jul 31

Movement Alert|GENSCRIPT BIO Rises 5.47% in Regular Trading, CARVYKTI Q2 Sales Surge Nearly 50% Year-over-Year Boosting Sentiment

Market Focus
·
Jul 31

Selling US$5.8m Of Stock Was Lucrative Decision For Genscript Biotech Insiders

Simply Wall St.
·
Jul 28

Movement Alert|GENSCRIPT BIO Intraday Rise 5.38%, CARVYKTI Q2 Sales Up Nearly 50% YoY Fueling Continued Technical Recovery

Market Focus
·
Jul 23

Market Analysis: Tech Stocks Retreat on Capex Worries, Gold Gains on Safe-Haven Logic

Stock News
·
Jul 22

Movement Alert|Genscript Biotech Rises 5.12% in Regular Trading, WAIC AI Bio-Manufacturing Platform Showcase Extends Technical Rebound

Market Focus
·
Jul 22

Movement Alert|Genscript Biotech Rises 5.6% in Regular Trading, WAIC AI Biomanufacturing Platform Showcase and Sector Rebound Boost Sentiment

Market Focus
·
Jul 20

Movement Alert|Genscript Biotech Falls 5.18% in Regular Trading, CARVYKTI Q2 Sales Growth Deceleration Extends Profit-Taking Pressure

Market Focus
·
Jul 17

Genscript Associate Reports $657 Million in Carvykti Sales Under License Agreement

MT Newswires Live
·
Jul 16

Movement Alert|GenScript Biotech Falls 6.34% in Regular Trading, CARVYKTI Q2 Sales Growth Deceleration Triggers Profit-Taking

Market Focus
·
Jul 16

Genscript Biotech: Associate Legend Biotech Posts US$657.00 Million Q2 Sales for CARVYKTI®

Bulletin Express
·
Jul 15